BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, Coppola N. Hepatitis B virus burden in developing countries. World J Gastroenterol 2015; 21(42): 11941-11953 [PMID: 26576083 DOI: 10.3748/wjg.v21.i42.11941] [Cited by in CrossRef: 107] [Cited by in F6Publishing: 97] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Du Y, Zhang S, Hu M, Wang Q, Liu N, Shen H, Zhang Y, Yan D, Zhang M. Association between hepatitis B virus infection and chronic kidney disease: A cross-sectional study from 3 million population aged 20 to 49 years in rural China. Medicine (Baltimore) 2019;98:e14262. [PMID: 30702585 DOI: 10.1097/MD.0000000000014262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Hu AQ, Cai QY, Zhang M, Liu HY, Wang TL, Han WH, Li Q, Fan W, Li YJ, He YN, Zheng YJ. Overt and occult hepatitis B infection after neonatal vaccination: mother-to-infant transmission and HBV vaccine effectiveness. Int J Infect Dis 2021;104:601-9. [PMID: 33508476 DOI: 10.1016/j.ijid.2021.01.045] [Reference Citation Analysis]
3 Aljumah AA, Babatin M, Hashim A, Abaalkhail F, Bassil N, Safwat M, Sanai FM. Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions. Saudi J Gastroenterol 2019;25:73-80. [PMID: 30720000 DOI: 10.4103/sjg.SJG_421_18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
4 Soares E, Cordeiro R, Faneca H, Borges O. Polymeric nanoengineered HBsAg DNA vaccine designed in combination with β‑glucan. International Journal of Biological Macromolecules 2019;122:930-9. [DOI: 10.1016/j.ijbiomac.2018.11.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
5 Kasera GO, Maingi JM, Onyango OK, Nyamache AK. Prevalence and Genetic Diversity of HAV and HBV Viruses among Jaundice Patients at Coast General Hospital, Mombasa County, Kenya. Malays J Med Sci 2021;28:56-64. [PMID: 34285644 DOI: 10.21315/mjms2021.28.3.5] [Reference Citation Analysis]
6 Mokaya J, Burn EAO, Tamandjou CR, Goedhals D, Barnes EJ, Andersson M, Pinedo-Villanueva R, Matthews PC. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa. BMC Public Health 2019;19:829. [PMID: 31242901 DOI: 10.1186/s12889-019-7095-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Li H, Xu QY, Xie Y, Luo JJ, Cao HX, Pan Q. Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis. Ann Hepatol. 2021;24:100316. [PMID: 33515803 DOI: 10.1016/j.aohep.2021.100316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Umutesi J, Simmons B, Makuza JD, Dushimiyimana D, Mbituyumuremyi A, Uwimana JM, Ford N, Mills EJ, Nsanzimana S. Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda. BMC Infect Dis 2017;17:315. [PMID: 28464899 DOI: 10.1186/s12879-017-2422-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
9 Ogunfemi MK, Olawumi HO, Olokoba AB, Kagu MB, Biliaminu SA, Durowade KA, Durotoye IA, Shittu AO. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study. Malawi Med J 2017;29:32-6. [PMID: 28567194 DOI: 10.4314/mmj.v29i1.7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
10 Hebo HJ, Gemeda DH, Abdusemed KA. Hepatitis B and C Viral Infection: Prevalence, Knowledge, Attitude, Practice, and Occupational Exposure among Healthcare Workers of Jimma University Medical Center, Southwest Ethiopia. ScientificWorldJournal 2019;2019:9482607. [PMID: 30853866 DOI: 10.1155/2019/9482607] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Colucci G, Renteria SU, Lunghi G, Ceriotti F, Sguazzini E, Spalenza S, Regazzo C, Lampertico P, Colombo M. Italian Migrants Study: an HCV and HBV Micro-Elimination Pilot Project. Clin Res Hepatol Gastroenterol 2021;:101852. [PMID: 34923181 DOI: 10.1016/j.clinre.2021.101852] [Reference Citation Analysis]
12 Chipetah F, Chirambo A, Billiat E, Shawa IT. Hepatitis B virus seroprevalence among Malawian medical students: A cross-sectional study. Malawi Med J 2017;29:29-31. [PMID: 28567193 DOI: 10.4314/mmj.v29i1.6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Kakuda TN, Yogaratnam JZ, Westland C, Gane EJ, Schwabe C, Vuong J, Patel M, Snoeys J, Talloen W, Lenz O, Fry J, Chanda S, van Remoortere P. Pharmacokinetics, safety and tolerability of single- and multiple-ascending doses of JNJ-64530440, a novel hepatitis B virus capsid assembly modulator, in healthy volunteers. Antiviral Therapy 2021;26:13-24. [DOI: 10.1177/13596535211044331] [Reference Citation Analysis]
14 Mengiste DA, Dirbsa AT, Ayele BH, Hailegiyorgis TT. Hepatitis B virus infection and its associated factors among medical waste collectors at public health facilities in eastern Ethiopia: a facility-based cross-sectional study. BMC Infect Dis 2021;21:233. [PMID: 33639871 DOI: 10.1186/s12879-021-05918-x] [Reference Citation Analysis]
15 Fan W, Zhang M, Zhu YM, Zheng YJ. Immunogenicity of Hepatitis B Vaccine in Preterm or Low Birth Weight Infants: A Meta-Analysis. Am J Prev Med 2020;59:278-87. [PMID: 32564973 DOI: 10.1016/j.amepre.2020.03.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Makuza JD, Rwema JOT, Ntihabose CK, Dushimiyimana D, Umutesi J, Nisingizwe MP, Serumondo J, Semakula M, Riedel DJ, Nsanzimana S. Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda. BMC Infect Dis 2019;19:381. [PMID: 31053097 DOI: 10.1186/s12879-019-4013-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
17 Sundberg I, Lannergård A, Ramklint M, Cunningham JL. Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study. BMC Psychiatry 2018;18:157. [PMID: 29843679 DOI: 10.1186/s12888-018-1735-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
18 Shiferaw E, Tadilo W, Melkie I, Shiferaw M. Sero-prevalence and trends of transfusion-transmissible infections among blood donors at Bahir Dar district blood bank, northwest Ethiopia: A four year retrospective study. PLoS One 2019;14:e0214755. [PMID: 30973906 DOI: 10.1371/journal.pone.0214755] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
19 Kissou SA, Koura M, Sawadogo A, Ouédraogo A-, Traoré H, Kamboulé E, Zogona WWF, Nacro B. [Serological markers of viral hepatitis B and C in children with sickle cell disease monitored in the Pediatrics Department at the University Hospital of Bobo-Dioulasso (Burkina Faso)]. Bull Soc Pathol Exot 2017;110:160-4. [PMID: 28417347 DOI: 10.1007/s13149-017-0555-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Marchese V, Beltrame A, Angheben A, Marocco S, Gaeta GB, Bisoffi Z. The impact of schistosomiasis co-infection in the presentation of viral hepatitis B in migrants: An observational study in non-endemic area. Travel Med Infect Dis 2020;35:101467. [PMID: 31449881 DOI: 10.1016/j.tmaid.2019.101467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Whitford K, Liu B, Micallef J, Yin JK, Macartney K, Van Damme P, Kaldor JM. Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis. Bull World Health Organ. 2018;96:484-497. [PMID: 29962551 DOI: 10.2471/blt.17.205153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
22 Kayondo SP, Byamugisha JK, Ntuyo P. Prevalence of hepatitis B virus infection and associated risk factors among pregnant women attending antenatal clinic in Mulago Hospital, Uganda: a cross-sectional study. BMJ Open 2020;10:e033043. [PMID: 32499255 DOI: 10.1136/bmjopen-2019-033043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Hamida ME, Raja SM, Petros Y, Wahab M, Seyoum Y, Elkhidir IM, Tekle F. Prevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea. Sci Rep 2021;11:11323. [PMID: 34059763 DOI: 10.1038/s41598-021-90836-w] [Reference Citation Analysis]
24 Poole S, Townsend J, Wertheim H, Kidd SP, Welte T, Schuetz P, Luyt CE, Beishuizen A, Jensen JS, Del Castillo JG, Plebani M, Saeed K. How are rapid diagnostic tests for infectious diseases used in clinical practice: a global survey by the International Society of Antimicrobial Chemotherapy (ISAC). Eur J Clin Microbiol Infect Dis 2021;40:429-34. [PMID: 32902760 DOI: 10.1007/s10096-020-04031-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Reference Citation Analysis]
26 Tandoh KZ, Kusi KA, Archampong TN, Boamah I, Quaye O. Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohort. Exp Biol Med (Maywood) 2020;245:815-22. [PMID: 32349537 DOI: 10.1177/1535370220921118] [Reference Citation Analysis]
27 Bilounga Ndongo C, Eteki L, Siedner M, Mbaye R, Chen J, Ntone R, Donfack O, Bongwong B, Essaka Evoue R, Zeh F, Njouom R, Nguefack-Tsague G, Etoundi Mballa GA, Biwole Sida M, Boum Y. Prevalence and vaccination coverage of Hepatitis B among healthcare workers in Cameroon: A national seroprevalence survey. J Viral Hepat 2018;25:1582-7. [PMID: 30047565 DOI: 10.1111/jvh.12974] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
28 Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, Dusheiko G, Gogela N, Kassianides C, Kew M, Lam P, Lesi O, Lohouès-Kouacou MJ, Mbaye PS, Musabeyezu E, Musau B, Ojo O, Rwegasha J, Scholz B, Shewaye AB, Tzeuton C, Sonderup MW; Gastroenterology and Hepatology Association of sub-Saharan Africa (GHASSA). Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol 2017;2:900-9. [PMID: 29132759 DOI: 10.1016/S2468-1253(17)30295-9] [Cited by in Crossref: 98] [Cited by in F6Publishing: 62] [Article Influence: 24.5] [Reference Citation Analysis]
29 Drazilova S, Kristian P, Janicko M, Halanova M, Safcak D, Dorcakova PD, Marekova M, Pella D, Madarasova-Geckova A, Jarcuska P, HepaMeta Team. What is the Role of the Horizontal Transmission of Hepatitis B Virus Infection in Young Adult and Middle-Aged Roma Population Living in the Settlements in East Slovakia? Int J Environ Res Public Health. 2020;17:3293. [PMID: 32397342 DOI: 10.3390/ijerph17093293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Kim M, Paik J, Golabi P, Jeffers T, Mishra A, Younossi ZM. Resource Utilization and Outcomes of Medicare Recipients With Chronic Hepatitis B in the United States. J Clin Gastroenterol 2019;53:e341-7. [PMID: 30106839 DOI: 10.1097/MCG.0000000000001110] [Reference Citation Analysis]
31 Machmud PB, Glasauer S, Gottschick C, Mikolajczyk R. Knowledge, Vaccination Status, and Reasons for Avoiding Vaccinations against Hepatitis B in Developing Countries: A Systematic Review. Vaccines (Basel) 2021;9:625. [PMID: 34207829 DOI: 10.3390/vaccines9060625] [Reference Citation Analysis]
32 Auta A, Adewuyi EO, Tor-anyiin A, Edor JP, Kureh GT, Khanal V, Oga E, Adeloye D. Global prevalence of percutaneous injuries among healthcare workers: a systematic review and meta-analysis. International Journal of Epidemiology 2018;47:1972-80. [DOI: 10.1093/ije/dyy208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
33 Sagnelli C, Sagnelli E, Russo A, Pisaturo M, Occhiello L, Coppola N. HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges. Life (Basel) 2021;11:169. [PMID: 33671730 DOI: 10.3390/life11020169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Seremba E, Van Geertruyden JP, Ssenyonga R, Opio CK, Kaducu JM, Sempa JB, Colebunders R, Ocama P. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda. Vaccine 2017;35:2937-42. [PMID: 28434689 DOI: 10.1016/j.vaccine.2017.04.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol 2017;31:239-47. [PMID: 28774405 DOI: 10.1016/j.bpg.2017.05.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
36 Fentiman IS. The endocrinology of male breast cancer. Endocr Relat Cancer 2018;25:R365-73. [PMID: 29752333 DOI: 10.1530/ERC-18-0117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Sievert K, O’neill P, Koh Y, Lee J, Dev A, Le S. Barriers to Accessing Testing and Treatment for Chronic Hepatitis B in Afghan, Rohingyan, and South Sudanese Populations in Australia. J Immigrant Minority Health 2018;20:140-6. [DOI: 10.1007/s10903-017-0546-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
38 Eskandari E, Dahmardeh T, Dahmardeh F, Pahlevani E, Metanat M. Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection. Virusdisease 2017;28:289-94. [PMID: 29291215 DOI: 10.1007/s13337-017-0391-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 D Goldenberg S, Merrick B. The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection. Ther Adv Infect Dis 2021;8:2049936120981526. [PMID: 33614028 DOI: 10.1177/2049936120981526] [Reference Citation Analysis]
40 Kupin WL. Viral-Associated GN: Hepatitis B and Other Viral Infections. Clin J Am Soc Nephrol 2017;12:1529-33. [PMID: 27797900 DOI: 10.2215/CJN.09180816] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
41 Sorgho PA, Martinson JJ, Djigma FW, Yonli AT, Nagalo BM, Compaore TR, Obiri-Yeboah D, Diarra B, Sombie HK, Zongo AW, Ouattara AK, Soubeiga STR, Traore L, Roberts LR, Simpore J. Insights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina Faso. Mediterr J Hematol Infect Dis 2018;10:e2018060. [PMID: 30416692 DOI: 10.4084/MJHID.2018.060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
42 Gomes C, Wong RJ, Gish RG. Global Perspective on Hepatitis B Virus Infections in the Era of Effective Vaccines. Clin Liver Dis 2019;23:383-99. [PMID: 31266615 DOI: 10.1016/j.cld.2019.04.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
43 Miquel M, Pardo A, Forné M, Martínez-Alpin G, Rodríguez-Castellano A, Casas M, Rosinach M, Roget M, Dalmau B, Temiño R, Quer JC, Sanchez-Delgado J, Ortiz J, Vergara M. Current trends in access to treatment for hepatitis B in immigrants vs non-immigrants. Gastroenterol Rep (Oxf) 2020;8:362-6. [PMID: 33163191 DOI: 10.1093/gastro/goaa010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Nankya-Mutyoba J, Aizire J, Makumbi F, Atuyambe L, Ocama P, Kirk GD. Correlates of hepatitis B awareness and disease-specific knowledge among pregnant women in Northern and Central Uganda: a cross-sectional study. Hepatol Med Policy 2018;3:14. [PMID: 30598844 DOI: 10.1186/s41124-018-0043-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Alemu AA, Zeleke LB, Aynalem BY, Kassa GM. Hepatitis B Virus Infection and Its Determinants among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis. Infect Dis Obstet Gynecol 2020;2020:9418475. [PMID: 32577077 DOI: 10.1155/2020/9418475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
46 Tesfa T, Hawulte B, Tolera A, Abate D. Hepatitis B virus infection and associated risk factors among medical students in eastern Ethiopia. PLoS One 2021;16:e0247267. [PMID: 33606777 DOI: 10.1371/journal.pone.0247267] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Chen M, Zhuang J, Zhou D, Xu Y, Zhao Y, Wang S, Zhang W, Duan M, Zhu T, Li J, Cai H, Cao X, Han B. Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection. Ann Hematol 2017;96:581-7. [PMID: 28084534 DOI: 10.1007/s00277-017-2918-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
48 Blanco RY, Loureiro CL, Villalba JA, Sulbarán YF, Maes M, de Waard JH, Rangel HR, Jaspe RC, Pujol FH. Decreasing prevalence of Hepatitis B and absence of Hepatitis C Virus infection in the Warao indigenous population of Venezuela. PLoS One 2018;13:e0197662. [PMID: 29799873 DOI: 10.1371/journal.pone.0197662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
49 Chen CM, Ouyang S, Lin LY, Wu LJ, Xie TA, Chen JJ, Li ZX, Zhu GD, Ji TX, Pan ZY, Xia Y, Guo XG. Diagnostic accuracy of LAMP assay for HBV infection. J Clin Lab Anal 2020;34:e23281. [PMID: 32157743 DOI: 10.1002/jcla.23281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
50 Sagnelli E, Alessio L, Sagnelli C, Gualdieri L, Pisaturo M, Minichini C, Di Caprio G, Starace M, Onorato L, Macera M, Scotto G, Coppola N. Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.13260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Pataccini G, Berini CA, Pedrozo WR, Biglione MM, Delfino CM. First molecular epidemiological study of hepatitis B and D in individuals infected with human T-lymphotropic virus 1/2 from Argentina. J Med Virol 2021;93:3995-8. [PMID: 32725912 DOI: 10.1002/jmv.26366] [Reference Citation Analysis]
52 Kengibe PY, Makulo JR, Nlandu YM, Lepira FB, Sumaili EK, Bukabau JB, Mbendi CN, Ahuka SM, Tshimpi AW, Ngoma PK, Mangani NN, Mbendi SN. Response to single dose hepatitis B vaccine in Congolese non-HIV hemodialysis patients: a prospective observational study. Pan Afr Med J 2019;34:122. [PMID: 33708291 DOI: 10.11604/pamj.2019.34.122.19603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Kim SE, Jang ES, Ki M, Gwak GY, Kim KA, Kim GA, Kim DY, Kim DJ, Kim MW, Kim YS, Kim YS, Kim IH, Kim CW, Kim HD, Kim HJ, Park NH, Baik SK, Suh JI, Song BC, Song IH, Yeon JE, Lee BS, Lee YJ, Jung YK, Chung WJ, Cho SB, Cho EY, Cho HC, Cheon GJ, Chae HB, Choi D, Choi SK, Choi HY, Tak WY, Heo J, Jeong SH. Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study. J Korean Med Sci 2018;33:e264. [PMID: 30310365 DOI: 10.3346/jkms.2018.33.e264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Hong SJ, Ahn MH, Lee YW, Pal S, Sangshetti J, Arote RB. Biodegradable Polymeric Nanocarrier-Based Immunotherapy in Hepatitis Vaccination. In: Chun HJ, Park CH, Kwon IK, Khang G, editors. Cutting-Edge Enabling Technologies for Regenerative Medicine. Singapore: Springer; 2018. pp. 303-20. [DOI: 10.1007/978-981-13-0950-2_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
55 Pisano MB, Giadans CG, Flichman DM, Ré VE, Preciado MV, Valva P. Viral hepatitis update: Progress and perspectives . World J Gastroenterol 2021; 27(26): 4018-4044 [PMID: 34326611 DOI: 10.3748/wjg.v27.i26.4018] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lanini S, Pisapia R, Capobianchi MR, Ippolito G. Global epidemiology of viral hepatitis and national needs for complete control. Expert Rev Anti Infect Ther 2018;16:625-39. [PMID: 30067107 DOI: 10.1080/14787210.2018.1505503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
57 Rickard J, Beilman G, Forrester J, Sawyer R, Stephen A, Weiser TG, Valenzuela J. Surgical Infections in Low- and Middle-Income Countries: A Global Assessment of the Burden and Management Needs. Surg Infect (Larchmt) 2020;21:478-94. [PMID: 31816263 DOI: 10.1089/sur.2019.142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
58 Wu YT, Li X, Liu ZL, Xu Z, Dai W, Zhang K, Wu JS, Arshad B, Wu KN, Kong LQ. Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis. PLoS One 2017;12:e0179680. [PMID: 28640902 DOI: 10.1371/journal.pone.0179680] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
59 Elzouki AN, Lubbad R, Elzouki I, Elhaddad A, Ibrahim A. Frequency of hepatitis B and C in health care providers at three referral hospitals in Libya. Pan Afr Med J 2020;37:214. [PMID: 33520053 DOI: 10.11604/pamj.2020.37.214.23997] [Reference Citation Analysis]
60 Iradukunda PG, Habyarimana T, Niyonzima FN, Uwitonze AY, Mpunga T. Risk factors associated with hepatitis B and C in rural population of Burera district, Rwanda. Pan Afr Med J 2020;35:43. [PMID: 32499858 DOI: 10.11604/pamj.2020.35.43.16226] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Subic M, Zoulim F. How to improve access to therapy in hepatitis B patients. Liver Int 2018;38 Suppl 1:115-21. [PMID: 29427482 DOI: 10.1111/liv.13640] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
62 Ginzberg D, Wong RJ, Gish R. Global HBV burden: guesstimates and facts. Hepatol Int 2018;12:315-29. [DOI: 10.1007/s12072-018-9884-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
63 Omatola CA, Idofe J, Okolo MO, Adejo PO, Maina MM, Oyiguh JA. Seroprevalence of HBV among people living with HIV in Anyigba, Kogi State, Nigeria. Afr Health Sci 2019;19:1938-46. [PMID: 31656477 DOI: 10.4314/ahs.v19i2.17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
64 Drazilova S, Janicko M, Kristian P, Schreter I, Halanova M, Urbancikova I, Madarasova-Geckova A, Marekova M, Pella D, Jarcuska P; HepaMeta Team. Prevalence and Risk Factors for Hepatitis B Virus Infection in Roma and Non-Roma People in Slovakia. Int J Environ Res Public Health. 2018;15:1047. [PMID: 29789486 DOI: 10.3390/ijerph15051047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
65 Tayefinasrabadi H, Mohebbi SR, Hosseini SM, Azimzadeh P, Pourhoseingholi MA, Ghaemi A, Sharifian A, Asadzadeh Aghdaei H, Zali MR. Association of Interleukin-17 gene polymorphisms with susceptibility to chronic hepatitis B virus infection and clearance in Iranian population. Microb Pathog 2020;144:104195. [PMID: 32294519 DOI: 10.1016/j.micpath.2020.104195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Bekele Y, Yibeltal D, Bobosha K, Andargie TE, Lemma M, Gebre M, Mekonnen E, Habtewold A, Nilsson A, Aseffa A, Howe R, Chiodi F. T follicular helper cells and antibody response to Hepatitis B virus vaccine in HIV-1 infected children receiving ART. Sci Rep 2017;7:8956. [PMID: 28827754 DOI: 10.1038/s41598-017-09165-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
67 Ji W, Xie N, He D, Wang W, Li H, Wang K. Age-Period-Cohort Analysis on the Time Trend of Hepatitis B Incidence in Four Prefectures of Southern Xinjiang, China from 2005 to 2017. Int J Environ Res Public Health 2019;16:E3886. [PMID: 31615013 DOI: 10.3390/ijerph16203886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Villar LM, Cruz HM, Portilho MM, Barbosa JR, Mendonça ACFD, Flores GL. Emergence of New Epidemiological Hepatitis B and C Profiles in High Risk Groups in Latin America. In: Majumder MAA, Kabir R, Rahman S, editors. Public Health - Emerging and Re-emerging Issues. InTech; 2018. [DOI: 10.5772/intechopen.79174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Miao N, Zheng H, Sun X, Shen L, Wang F, Cui F, Yin Z, Zhang G, Wang F. Enhanced sentinel surveillance for hepatitis B infection in 200 counties in China, 2013-2016. PLoS One 2019;14:e0215580. [PMID: 31013293 DOI: 10.1371/journal.pone.0215580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Chen C, Jiang X, Liu X, Guo L, Wang W, Gu S, Wen C, Yi X, Tang L, Li Y. Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay. J Leukoc Biol 2021;109:455-65. [PMID: 32620046 DOI: 10.1002/JLB.5MA0620-023RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Butt N, Ali Khan M, Haleem F, Butt S, Reema S, Qureshi T, Abbasi A. Epidemiology, Clinical Characteristics, and Management Status of Hepatitis B: A Cross-sectional Study in a Tertiary Care Hospital at Karachi, Pakistan. Cureus 2019;11:e3880. [PMID: 30899631 DOI: 10.7759/cureus.3880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Athamneh RY, Arıkan A, Sayan M, Mahafzah A, Sallam M. Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa. Pathogens 2021;10:1333. [PMID: 34684283 DOI: 10.3390/pathogens10101333] [Reference Citation Analysis]
73 Mojsiejczuk L, Elizalde MM, López G, Figueredo D, Marquez N, Campos RH, Flichman D. Molecular epidemiology of hepatitis B virus in Paraguay. Infect Genet Evol 2019;71:91-7. [PMID: 30910532 DOI: 10.1016/j.meegid.2019.03.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
74 Brandl M, Schmidt AJ, Marcus U, An der Heiden M, Dudareva S. Are men who have sex with men in Europe protected from hepatitis B? Epidemiol Infect 2020;148:e27. [PMID: 32052715 DOI: 10.1017/S0950268820000163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
75 Singh US, Mulamoottil VA, Chu CK. 2′-Fluoro-6′-methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti-HBV agent, active against drug-resistant HBV mutants. Med Res Rev 2018;38:977-1002. [DOI: 10.1002/med.21490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Kafeero HM, Ndagire D, Ocama P, Walusansa A, Sendagire H. Sero-prevalence of human immunodeficiency virus-hepatitis B virus (HIV-HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis.Virol J. 2020;17:170. [PMID: 33160386 DOI: 10.1186/s12985-020-01443-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
77 Silva RJS, do Nascimento RS, Oliveira-Neto JAJ, Silva FQ, Piauiense JNF, Gomes CM, Pinheiro LML, Resque RL, Pinho JRR, Kupek E, Fischer B, Machado LFA, Martins LC, Lemos JAR, Oliveira-Filho AB. Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region. Viruses 2021;13:1380. [PMID: 34372586 DOI: 10.3390/v13071380] [Reference Citation Analysis]
78 Chularojanamontri L, Nimanong S, Wongpraparut C, Silpa-Archa N, Chaiyabutr C, Charoenpipatsin N. Impact of long-term systemic treatment for psoriasis on liver disease in psoriasis patients with coexisting hepatitis B virus infection. Dermatol Ther 2020;33:e14008. [PMID: 32654402 DOI: 10.1111/dth.14008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Mahanama AIK, Samaraweera B, Niroshanie TT, Seethagala SSSAK, Abeynayake JI. Seroprevalence of hepatitis B and C virus infection among clinically suspected patients at state sector hospitals in Sri Lanka; a laboratory-based retrospective study. Infect Dis (Lond) 2019;51:706-9. [PMID: 31298063 DOI: 10.1080/23744235.2019.1640387] [Reference Citation Analysis]
80 Ahmad AE, Bakari AG, Musa BOP, Mustapha SK, Jamoh BY, Abdullahi IN, Tahir MI, Olatunji AO, Maishanu SH, Suleiman AB, Tolulope A, Hawkins C, Sagay AS, Zoakah A, Olayinka AT. Pattern of prevalent Hepatitis B virus genotypes in Zaria, Nigeria. Niger Postgrad Med J 2019;26:80-6. [PMID: 31187746 DOI: 10.4103/npmj.npmj_59_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Yu F, Li G, Hao W, Hu W. Hepatitis B Virus-Related Glomerulonephritis with Positive and Negative Serum HBsAg: Different Clinicopathologic Characteristics of Two Clinical Subtypes. Int J Gen Med 2021;14:3069-77. [PMID: 34234535 DOI: 10.2147/IJGM.S318087] [Reference Citation Analysis]
82 Wu H, Zhao C, Adhikari VP, Lu L, Huang J, Wei Y, Luo Q, Dai W, Wu Y, Li X, Wu K, Kong LQ. The prevalence and clinicopathological features of breast cancer patients with hepatitis B virus infection in China. Oncotarget 2017;8:18185-90. [PMID: 28212549 DOI: 10.18632/oncotarget.15305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
83 Jose-Abrego A, Panduro A, Fierro NA, Roman S. High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differential risk factors among Mexican risk populations with low socioeconomic status. J Med Virol 2017;89:2149-57. [PMID: 28792071 DOI: 10.1002/jmv.24913] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
84 Auta A, Adewuyi EO, Kureh GT, Onoviran N, Adeloye D. Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis.Vaccine. 2018;36:4851-4860. [PMID: 29970299 DOI: 10.1016/j.vaccine.2018.06.043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
85 Omatola CA, Onoja BA, Agama J. Detection of Hepatitis B Surface Antigen among Febrile Patients in Ankpa, Kogi State, Nigeria. J Trop Med 2020;2020:5136785. [PMID: 32095141 DOI: 10.1155/2020/5136785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Li Z, Xu J, Cui H, Song J, Chen J, Wei J. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus. Medicine (Baltimore) 2020;99:e20302. [PMID: 32443377 DOI: 10.1097/MD.0000000000020302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Caviglia GP, Troshina Y, Garro E, Gesualdo M, Aneli S, Birolo G, Pittaluga F, Cavallo R, Saracco GM, Ciancio A. Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study. J Clin Med 2021;10:3308. [PMID: 34362093 DOI: 10.3390/jcm10153308] [Reference Citation Analysis]
88 Adeyemi OO, Herod MR, Oladiji F, Fakunle YM, Babatunde AS, Agbede OO. A multi-template multiplex PCR assay for hepatitis B virus and human β-globin. J Med Virol 2017;89:1944-51. [PMID: 28618003 DOI: 10.1002/jmv.24877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
89 Sagnelli C, Ciccozzi M, Alessio L, Cella E, Gualdieri L, Pisaturo M, Minichini C, Di Caprio G, Starace M, Onorato L, Capoprese M, Occhiello L, Angeletti S, Scotto G, Macera M, Sagnelli E, Coppola N. HBV molecular epidemiology and clinical condition of immigrants living in Italy. Infection. 2018;46:523-531. [PMID: 29796738 DOI: 10.1007/s15010-018-1153-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
90 Al-Jubran KM, Al-Dossary MA, Elsafi SH. The declining rates of hepatitis B carriage among adolescents and young people in the Eastern region of Saudi Arabia. Saudi Med J 2016;37:864-70. [PMID: 27464863 DOI: 10.15537/smj.2016.8.14494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
91 Nannini P, Sokal EM. Hepatitis B: changing epidemiology and interventions. Arch Dis Child. 2017;102:676-680. [PMID: 27986700 DOI: 10.1136/archdischild-2016-312043] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
92 Van Damme P, Leroux-Roels G, Suryakiran P, Folschweiller N, Van Der Meeren O. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine. Hum Vaccin Immunother 2017;13:972-80. [PMID: 28281907 DOI: 10.1080/21645515.2016.1274473] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
93 Wungu CDK, Amin M, Ruslan SEN, Purwono PB, Kholili U, Maimunah U, Setiawan PB, Lusida MI, Soetjipto S, Handajani R. Association between host TNF-α, TGF-β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients. Biomed Rep 2019;11:145-53. [PMID: 31565220 DOI: 10.3892/br.2019.1239] [Reference Citation Analysis]
94 Paboriboune P, Vial T, Chassagne F, Sitbounlang P, Soundala S, Bertani S, Sengmanothong D, Babin FX, Steenkeste N, Dény P, Pineau P, Deharo E. A Seven-Year Retrospective Study on the Surveillance of Hepatitis B in Laos. Int J Hepatol 2018;2018:9462475. [PMID: 29805811 DOI: 10.1155/2018/9462475] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Tunnage J, Yates A, Nwoga C, Sing'oei V, Owuoth J, Polyak CS, Crowell TA; RV393 Study Group. Hepatitis and tuberculosis testing are much less common than HIV testing among adults in Kisumu, Kenya: results from a cross-sectional assessment. BMC Public Health 2021;21:1143. [PMID: 34130663 DOI: 10.1186/s12889-021-11164-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Mpody C, Thompson P, Tabala M, Ravelomanana NLR, Malongo F, Kawende B, Behets F, Okitolonda E, Yotebieng M; CQI-PMTCT study team. Hepatitis B infection among pregnant and post-partum women living with HIV and on antiretroviral therapy in Kinshasa, DR Congo: A cross-sectional study. PLoS One 2019;14:e0216293. [PMID: 31071145 DOI: 10.1371/journal.pone.0216293] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
97 Luo A, Jiang X, Ren H. Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis. Virol J 2018;15:139. [PMID: 30201035 DOI: 10.1186/s12985-018-1050-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
98 Reekie J, Kaldor JM, Mak DB, Ward J, Donovan B, Hocking JS, Preen D, Liu B. Long-term impact of childhood hepatitis B vaccination programs on prevalence among Aboriginal and non-Aboriginal women giving birth in Western Australia. Vaccine 2018;36:3296-300. [PMID: 29706293 DOI: 10.1016/j.vaccine.2018.04.057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
99 Reuter TQ, Gomes-Gouvea M, Chuffi S, Duque UH, Carvalho JA, Perini W, Queiroz MM, Segal IM, Azevedo RS, Pinho JRR. Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis B. Ann Hepatol 2021;:100574. [PMID: 34743021 DOI: 10.1016/j.aohep.2021.100574] [Reference Citation Analysis]
100 Yerima A, Akintayo R, Adebajo A. Implications of a diagnosis of rheumatoid arthritis in resource-poor countries. Best Pract Res Clin Rheumatol 2021;:101725. [PMID: 34906416 DOI: 10.1016/j.berh.2021.101725] [Reference Citation Analysis]
101 Zhang C, Ötjengerdes RM, Roewe J, Mejias R, Marschall ALJ. Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology. BioDrugs 2020;34:435-62. [PMID: 32301049 DOI: 10.1007/s40259-020-00419-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]